Hong Kong (HSI) Groei aandelen Pharmaceuticals & Biotech

Name: Financiële inzichten gebaseerd op S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED May 04, 2026

Ontdek Hong Kong Pharmaceuticals & Biotech Groeiaandelen die op de HSI. Gesorteerd op voorspelde groei, hebben deze Pharmaceuticals & Biotech Stocks een hoger dan verwachte winst- of omzetgroei in vergelijking met andere bedrijven.

124 bedrijven

Bedrijf	Laatste prijs	7D Terugkeer	1 J Rendement	Marktkapitalisatie	Doel analisten	Waardering	Groei	Div Opbrengst
3696	HK$64.30	-2.4%	n/a	HK$36.8b	HK$77.41	83.6	140.6%	n/a
570	HK$1.72	0.6%	-14.9%	HK$8.7b	HK$1.86	0.4	113.8%	0%
9606	HK$273.40	-3.0%	26.8%	HK$24.7b	HK$436.31	11.6	101.0%	n/a
2487	HK$4.60	-2.3%	-23.7%	HK$1.7b	HK$12.72	4.3	100.8%	n/a
1548	HK$13.31	-2.2%	19.1%	HK$29.1b	HK$17.67	3.9	97.9%	0%
2591	HK$14.18	-10.9%	n/a	HK$6.5b	HK$31.49	42.9	95.4%	n/a
1477	HK$7.24	-4.1%	33.1%	HK$5.9b	HK$9.51	6.4	94.6%	n/a
1877	HK$25.20	-3.4%	55.0%	HK$42.0b	HK$29.74	9.0	93.1%	n/a
2171	HK$21.48	-11.2%	34.8%	HK$11.6b	HK$20.01	80.2	83.6%	n/a
2616	HK$9.35	-5.3%	222.4%	HK$14.9b	HK$14.20	48.3	83.5%	n/a
1952	HK$34.62	-2.1%	-31.9%	HK$12.2b	HK$50.16	6.2	83.2%	n/a
2595	HK$41.56	-13.6%	n/a	HK$15.4b	HK$59.23	103.0	83.0%	n/a
2480	HK$23.00	-7.9%	4.5%	HK$4.6b	HK$31.00	6.0	77.1%	n/a
2561	HK$25.10	0.5%	-44.4%	HK$2.7b	HK$50.79	17546.2	71.5%	n/a
2228	HK$9.53	12.6%	86.5%	HK$41.0b	HK$10.26	289.0	62.4%	n/a
2629	HK$12.41	0%	n/a	HK$3.7b	HK$100.01	22.1	57.9%	n/a
6185	HK$29.20	-9.6%	-12.8%	HK$11.9b	HK$48.52	5.6	57.2%	0%
2162	HK$73.95	-2.2%	54.1%	HK$21.8b	HK$93.35	26.5	57.1%	n/a
9887	HK$78.40	-7.8%	n/a	HK$15.6b	HK$94.89	76.7	54.9%	n/a
2565	HK$24.64	-12.3%	n/a	HK$14.5b	HK$101.80	18.7	49.9%	n/a
460	HK$1.26	-4.5%	70.3%	HK$11.4b	HK$2.00	55.3	49.2%	1.7%
9926	HK$127.80	-6.9%	45.6%	HK$117.7b	HK$173.10	33.6	46.8%	n/a
6990	HK$461.00	-1.2%	34.1%	HK$107.5b	HK$533.85	45.5	43.7%	n/a
2315	HK$52.80	-10.3%	279.9%	HK$43.0b	n/a	70.8	40.0%	n/a

Page 1 of 6